Logo image of CLDX

CELLDEX THERAPEUTICS INC (CLDX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CLDX - US15117B2025 - Common Stock

27.76 USD
+1.48 (+5.63%)
Last: 1/7/2026, 8:00:00 PM
27.76 USD
0 (0%)
After Hours: 1/7/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CLDX revenue by date.CLDX revenue by date.
2.36M
-49.25%
6.883M
191.65%
7.02M
1.99%
2.655M
-62.18%
3.178M
19.70%
9.71M
205.54%
162.9M
1,577.65%
529.78M
225.22%
1.01B
90.65%
1.376B
36.24%
1.849B
34.38%
EBITDA
YoY % growth
CLDX ebitda by date.CLDX ebitda by date.
-97.33M
-50.50%
-139.034M
-42.85%
-191.901M
-38.02%
-265.308M
-38.25%
-300.041M
-13.09%
-343.888M
-14.61%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
CLDX ebit by date.CLDX ebit by date.
-100.23M
-47.96%
-142.042M
-41.72%
-195.078M
-37.34%
-275.589M
-41.27%
-323.954M
-17.55%
-359.549M
-10.99%
-246.3M
31.50%
14.958M
106.07%
377.19M
2,421.66%
737.28M
95.47%
1.123B
52.32%
Operating Margin
CLDX operating margin by date.CLDX operating margin by date.
-4,247.03%-2,063.66%-2,778.89%-10,380.00%-10,193.66%-3,702.87%-151.20%2.82%37.35%53.58%60.74%
EPS
YoY % growth
CLDX eps by date.CLDX eps by date.
-2.21
-34.76%
-2.91
-31.67%
-2.45
15.81%
-3.73
-52.04%
-4.47
-19.97%
-4.72
-5.62%
-4.25
10.00%
-1.36
68.07%
2.74
302.07%
7.58
176.65%
12.82
69.07%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.02
-43.56%
-1.09
-34.74%
-1.12
-31.37%
-1.16
-15.09%
-1.14
-12.23%
Revenue
Q2Q % growth
1.618M
37.70%
665.04K
-4.31%
665.04K
-8.90%
767.04K831.3K
-48.62%
EBITDA
Q2Q % growth
-71.423M
-35.14%
-67.458M
-9.03%
-68.591M
-10.42%
-70.357M
0.98%
N/A
EBIT
Q2Q % growth
-75.328M
-34.45%
-77.939M
-24.23%
-79.354M
-24.27%
-80.833M
-9.80%
-84.852M
-12.64%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.01
-57.81%
-0.92-0.09-9.94%
Q2 2025
Q2Q % growth
-0.85
-57.41%
-0.870.022.62%
Q1 2025
Q2Q % growth
-0.81
-44.64%
-0.77-0.04-5.18%
Q4 2024
Q2Q % growth
-0.71
14.46%
-0.750.045.21%
Q3 2024
Q2Q % growth
-0.64
20.99%
-0.690.056.71%
Q2 2024
Q2Q % growth
-0.54
16.92%
-0.600.069.93%
Q1 2024
Q2Q % growth
-0.56
9.68%
-0.710.1520.89%
Q4 2023
Q2Q % growth
-0.83
-48.21%
-0.76-0.07-9.41%
Q3 2023
Q2Q % growth
-0.81
-42.11%
-0.69-0.12-17.03%
Q2 2023
Q2Q % growth
-0.65
-10.17%
-0.680.034.41%
Q1 2023
Q2Q % growth
-0.62
-26.53%
-0.640.023.82%
Q4 2022
Q2Q % growth
-0.56
-30.23%
-0.600.046.95%
Q3 2022
Q2Q % growth
-0.57
-26.67%
-0.590.023.09%
Q2 2022
Q2Q % growth
-0.59
-73.53%
-0.52-0.07-13.42%
Q1 2022
Q2Q % growth
-0.49
-16.67%
-0.46-0.03-5.81%
Q4 2021
Q2Q % growth
-0.43
21.82%
-0.430.00-1.18%
Q3 2021
Q2Q % growth
-0.45
-25.00%
-0.37-0.08-22.55%
Q2 2021
Q2Q % growth
-0.34
32.00%
-0.410.0716.67%
Q1 2021
Q2Q % growth
-0.42
42.47%
-0.39-0.03-8.36%
Q4 2020
Q2Q % growth
-0.55 -0.37-0.18-47.06%
Q3 2020
Q2Q % growth
-0.36 -0.370.011.96%
Q2 2020
Q2Q % growth
-0.50 -0.590.0915.48%
Q1 2020
Q2Q % growth
-0.73 -0.72-0.01-0.80%
CLDX Yearly EPS VS EstimatesCLDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 -20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth

-100.00%
1.005M-1.005M-100.00%
Q2 2025
Q2Q % growth
730K
-70.78%
1.027M-297K-28.92%
Q1 2025
Q2Q % growth
695K
345.51%
1.067M-372K-34.86%
Q4 2024
Q2Q % growth
1.175M
-71.56%
1.138M37K3.25%
Q3 2024
Q2Q % growth
3.191M
110.35%
844.866K2.346M277.69%
Q2 2024
Q2Q % growth
2.498M
832.09%
836.839K1.661M198.50%
Q1 2024
Q2Q % growth
156K
-83.87%
934.065K-778.065K-83.30%
Q4 2023
Q2Q % growth
4.132M
156.65%
859.717K3.272M380.62%
Q3 2023
Q2Q % growth
1.517M
270.00%
586.837K930.163K158.50%
Q2 2023
Q2Q % growth
268K
67.50%
538.56K-270.56K-50.24%
Q1 2023
Q2Q % growth
967K
468.82%
418.2K548.8K131.23%
Q4 2022
Q2Q % growth
1.61M
387.88%
269.28K1.341M497.89%
Q3 2022
Q2Q % growth
410K
173.33%
367.2K42.8K11.66%
Q2 2022
Q2Q % growth
160K
-95.40%
408K-248K-60.78%
Q1 2022
Q2Q % growth
170K
-75.36%
571.2K-401.2K-70.24%
Q4 2021
Q2Q % growth
330K
-91.29%
1.057M-727K-68.78%
Q3 2021
Q2Q % growth
150K
-77.61%
1.246M-1.096M-87.96%
Q2 2021
Q2Q % growth
3.48M
1,350.00%
656.197K2.824M430.33%
Q1 2021
Q2Q % growth
690K
-74.73%
816K-126K-15.44%
Q4 2020
Q2Q % growth
3.79M 612K3.178M519.28%
Q3 2020
Q2Q % growth
670K 402.9K267.1K66.29%
Q2 2020
Q2Q % growth
240K 816K-576K-70.59%
Q1 2020
Q2Q % growth
2.73M 1.01M1.72M170.30%
CLDX Yearly Revenue VS EstimatesCLDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -7.19% 0% -4.69%
Revenue0% 27.1% 0% -23.27%